Regulation Generic Drugmaker Impax to Pay $145 Mln to Finish Opioid Antitrust Litigation – Newest Tweet… Jul 21, 2022 Generic drugmaker Impax to pay $145 mln to end opioid antitrust litigation… Read More...
